A Congressional Research Service report (R48642, updated September 2025) documents the full arc of U.S. advanced-semiconductor export controls on China from 2018 through mid-2025, including identified gaps, workarounds, and countermeasures. Notably, it flags congressional concern over the Trump administration's approval of Nvidia H20 and AMD MI308 chip sales to China and the novel question of whether the U.S. government may lawfully receive proceeds from licensed chip sales, touching Article I, Section 9 and BIS fee-prohibition statutes. Structurally, the report crystallizes a contested policy pivot: controls that had progressively tightened under Biden are under partial reversal, with active debate over whether liberalization expands U.S. vendor addressable market or accelerates Chinese indigenous capability. For financial institutions, this is a formal signal that the regulatory floor for AI-chip exports to China is genuinely uncertain, with bipartisan congressional scrutiny creating headline and compliance risk for affected vendors.
335 other tracked developments touching the same claims.